Replacement of Lamivudine by Telbivudine to Improve Renal Function for Post-transplant Hepatitis B Patients - a Randomized Clinical Trial
Phase of Trial: Phase II/III
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Telbivudine (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 09 Feb 2017 Last checked against ClinicalTrials.gov record.
- 07 Apr 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2015 New trial record